Search

Your search keyword '"Pietroboni A. M."' showing total 130 results

Search Constraints

Start Over You searched for: Author "Pietroboni A. M." Remove constraint Author: "Pietroboni A. M."
130 results on '"Pietroboni A. M."'

Search Results

1. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

6. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

7. Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status

8. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

9. Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.

10. Signs and symptoms of COVID-19 in patients with multiple sclerosis

12. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

14. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales

16. Signs and symptoms of COVID-19 in patients with multiple sclerosis

17. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

18. Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses

19. Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience

20. Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition

21. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

24. Diogenes syndrome in dementia: a case report

25. Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome

27. Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis

28. Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease

29. Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.

30. Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there?

31. Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study

34. LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients

35. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

36. CSF β-amyloid predicts prognosis in patients with multiple sclerosis

37. Differentiating Vogt-Koyanagi-Harada syndrome from recurrent optic neuritis: a case report and review of the literature concerning Hispanic patients

38. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

39. CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease

40. Recognition of viral and self-antigens by T H 1 and T H 1/T H 17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses

41. CSF β-amyloid predicts prognosis in patients with multiple sclerosis.

42. Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study.

43. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.

44. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.

45. CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

46. CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.

49. CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

50. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

Catalog

Books, media, physical & digital resources